Clean ClAImsFirst Pass

AKASA vs CodaMetrix

Two Autonomous Medical Coding vendors, side by side. Facts from public sources; judgments are ours.

At a glance

Derived from public facts · a rough scale, not a ranking

AKASACodaMetrix
Pricing model

Enterprise contract (custom) · Subscription sized by transaction volume

Not published · Enterprise quotes only

Speed to go live

60-90 days typical; longer multi-facility

Four-plus months including silent learning phase

Automation model

Autonomous agents · GenAI automation with human review

Autonomous agents · autonomous coding with exception review

Built for

Mid-size groups, Enterprise systems

Enterprise systems

Security posture

HITRUST, SOC 2 Type II, HIPAA

SOC 2 Type II, ISO 27001, HIPAA

Company maturity

8 yrs (est. 2018)

7 yrs (est. 2019)

Financial backing

$205M · Series B

$110M+ · Series B

Named customers

2 named

5 named

Published results

Specific numbers public

No public numbers

Documented integrations

3 listed

1 listed

Third-party validation

None found

None found

Bottom line

  • Pick AKASA if you run a mid-size or large health system, ideally on Epic, and want generative AI working claims, auths, and coding in-house instead of outsourcing staff.
  • Pick CodaMetrix if you are a large academic or multi-specialty health system ready to fund a months-long project to automate coding at scale.

AKASA

Generative AI for coding and revenue cycle operations

Founded
2018
HQ
South San Francisco, CA
Stage
Series B
Raised
$205M

What it does

  • Generative AI medical coding trained on clinical documentation
  • Clinical documentation integrity (CDI) review at scale
  • Automates prior auth status and claims follow-up work
  • LLMs fine-tuned on customer clinical and financial data
  • Surfaces missed codes and documentation gaps pre-bill

Where it's strong

  • Cleveland Clinic co-developed and is now deploying its GenAI CDI product across all US locations, a rare tier-one clinical validation.
  • Deep pockets ($205M raised) and deployment across 650+ hospitals reduce vendor-viability risk.
  • Focus on mid-revenue-cycle (coding plus CDI) fits health systems that want one vendor for both.

What buyers should weigh

  • The company pivoted from RPA-style automation to generative AI, so ask which product generation you are actually buying.
  • Flagship proof points are large academic systems; fit and pricing for smaller hospitals is less proven.
  • Last disclosed raise was 2022, so probe current burn and roadmap funding.

Named customers

Cleveland Clinic · Duke University Health System

Integrations

EpicOracle Health (Cerner)FHIR/HL7 interfaces
Full AKASA profile →

CodaMetrix

Autonomous coding spun out of Mass General Brigham

Founded
2019
HQ
Boston, MA
Stage
Series B
Raised
$110M+

What it does

  • Autonomous coding of professional-fee charges from clinical notes
  • Covers radiology, pathology, surgery, and other specialties
  • Routes low-confidence cases to human coders
  • Clinically enriches claims data for audit and compliance
  • Customers report 60% coding cost and 70% denial reductions

Where it's strong

  • Spun out of Mass General Brigham's own billing operation, so the product was proven on real academic-center volume before it was sold.
  • Reference customers are elite academic systems (MGB, Mount Sinai, Yale, Henry Ford) with published outcome figures.
  • Confidence-based routing to human coders is an honest architecture: it automates what it can prove, not everything.

What buyers should weigh

  • Value scales with volume; it is built for large Epic-based health systems, not small physician groups.
  • Coverage is by specialty and service line, so confirm your highest-volume departments are actually supported.
  • At roughly $110M raised it is well capitalized for its niche but much smaller than the RCM incumbents it displaces.

Named customers

Mass General Brigham · Mount Sinai Health System · Yale Medicine · Henry Ford Health · University of Colorado Medicine

Integrations

Epic (available in Epic Toolbox)
Full CodaMetrix profile →

Compare against the rest of Autonomous Medical Coding

Deciding between these two?

First Pass tracks Autonomous Medical Coding every week: funding, launches, and what changed since this page was written.